Sorry, we were unable to verify the authenticity of this link. If you would like to proceed anyway, click the link below.

https://www.gov.uk/drug-safety-update/elvitegravir-boosted-with-cobicistat-avoid-use-in-pregnancy-due-to-risk-of-treatment-failure-and-maternal-to-child-transmission-of-hiv-1